Inscription Capital’s Clorox CLX Stock Holding History

Inscription Capital’s Portfolio CLX Stock Details CLX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-2,149	Closed	-$265K	–	691
2025 Q3	$265K	Buy	+2,149	New	+$267K	0.03%	508
2021 Q3	–	Sell	-3,112	Closed	-$560K	–	239
2021 Q2	$560K	Buy	+3,112	New	+$568K	0.06%	186

Other funds holding CLX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Inscription Capital's CLX Position: Q4 2025 in Review

Inscription Capital sold out of Clorox (CLX) in Q4 2025, closing a stake of 2,149 shares — an estimated $265K sold.

Inscription Capital first reported a position in CLX in Q2 2021 and held it in 2 quarters. The position peaked at $560K in Q2 2021. 1,053 funds tracked by Wall St. Rank hold CLX as of Q4 2025.

Inscription Capital reported no remaining Clorox position as of Q4 2025 after selling out during the quarter.
Inscription Capital sold 2,149 Clorox shares in Q4 2025, an estimated $265K.
Inscription Capital first reported a position in Clorox in Q2 2021 and held it in 2 quarters.
Inscription Capital's Clorox position peaked at $560K in Q2 2021.
1,053 funds tracked by Wall St. Rank held Clorox as of Q4 2025.

Based on Inscription Capital's 13F filing for Q4 2025, filed 29 Jan 2026.